Phreesia, Inc. (PHR)

USD 25.72

(1.94%)

EBITDA Summary of Phreesia, Inc.

Phreesia, Inc.'s latest annual EBITDA in 2024 was -102.94 Million USD , up 29.24% from previous year.
Phreesia, Inc.'s latest quarterly EBITDA in 2024 FY was N/A , up 32.01% from previous quarter.
Phreesia, Inc. reported an annual EBITDA of -145.48 Million USD in 2023, down -58.35% from previous year.
Phreesia, Inc. reported an annual EBITDA of -92.29 Million USD in 2022, down -878.34% from previous year.
Phreesia, Inc. reported a quarterly EBITDA of N/A for 2024 FY, up 32.01% from previous quarter.
Phreesia, Inc. reported a quarterly EBITDA of -24.58 Million USD for 2024 Q3, up 18.14% from previous quarter.

Annual EBITDA Chart of Phreesia, Inc. (2024 - 2018)

Historical Annual EBITDA of Phreesia, Inc. (2024 - 2018)

Year	EBITDA	EBITDA Growth
2024	-102.94 Million USD	29.24%
2023	-145.48 Million USD	-58.35%
2022	-92.29 Million USD	-878.34%
2021	-7.61 Million USD	-605.07%
2020	-3.72 Million USD	-53.51%
2019	2.1 Million USD	196.36%
2018	-4.91 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q4	-21.13 Million USD	8.58%
2024 FY	- USD	32.01%
2024 Q3	-24.58 Million USD	18.14%
2024 Q1	-30.91 Million USD	3.41%
2024 Q2	-30.17 Million USD	2.86%
2023 Q3	-33.12 Million USD	18.23%
2023 Q2	-40.51 Million USD	9.38%
2023 FY	- USD	-58.35%
2023 Q1	-44.71 Million USD	-9.65%
2023 Q4	-32.89 Million USD	0.72%
2022 Q2	-18.52 Million USD	-224.75%
2022 Q1	-5.7 Million USD	-41.6%
2022 Q3	-30.5 Million USD	-64.67%
2022 FY	- USD	-878.34%
2022 Q4	-40.77 Million USD	-33.65%
2021 Q2	-2.26 Million USD	-68.62%
2021 Q1	-1.34 Million USD	-32.64%
2021 Q3	-2.12 Million USD	6.48%
2021 Q4	-4.02 Million USD	-89.96%
2021 FY	- USD	-605.07%
2020 FY	- USD	-53.51%
2020 Q3	1.24 Million USD	-42.24%
2020 Q4	-1.01 Million USD	-181.32%
2020 Q2	2.15 Million USD	572.06%
2020 Q1	-457.32 Thousand USD	-206.42%
2019 FY	- USD	196.36%
2019 Q4	429.72 Thousand USD	-25.65%
2019 Q1	1.06 Million USD	0.0%
2019 Q2	2.08 Million USD	95.61%
2019 Q3	578 Thousand USD	-72.27%
2018 FY	- USD	0.0%

Peer EBITDA Comparison of Phreesia, Inc.

Name	EBITDA	EBITDA Difference
American Well Corporation	-225.99 Million USD	54.447%
Doximity, Inc.	195.46 Million USD	152.666%
Evolent Health, Inc.	-24.78 Million USD	-315.352%
MultiPlan Corporation	651.93 Million USD	115.791%
Teladoc Health, Inc.	153.99 Million USD	166.849%
Veeva Systems Inc.	429.33 Million USD	123.978%